EcoDrugPlus

Estrogen Receptor Beta-Like

Ensembl ID : ENSNBRG00000002405
Gene Symbol: LOC102794622
3 Cross references
198 Possible Orthologues:

Estrogen Receptor-Like

Ensembl ID : ENSNBRG00000018394
Gene Symbol: LOC102775904
3 Cross references
215 Possible Orthologues:

Estrogen-Related Receptor Gamma-Like

Ensembl ID : ENSNBRG00000002168
Gene Symbol: LOC102790695
3 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSNBRG00000012229
Gene Symbol: XPO1
3 Cross references
211 Possible Orthologues:

Exportin 1

Ensembl ID : ENSNBRG00000003776
Gene Symbol: XPO1
3 Cross references
224 Possible Orthologues:

Farnesyl Pyrophosphate Synthase-Like

Ensembl ID : ENSNBRG00000003942
Gene Symbol: LOC102795612
3 Cross references
267 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSNBRG00000007132
Gene Symbol: FGFR1
1 Cross references
203 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A-Like

Ensembl ID : ENSNBRG00000009641
Gene Symbol: LOC102793803
4 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2-Like

Ensembl ID : ENSNBRG00000015779
Gene Symbol: LOC102787384
3 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3-Like

Ensembl ID : ENSNBRG00000023909
Gene Symbol: LOC102798313
3 Cross references
193 Possible Orthologues:

Folate Receptor

Ensembl ID : ENSNBRG00000004782
Gene Symbol: FOLR
1 Cross references
436 Possible Orthologues:

Follicle-Stimulating Hormone Receptor-Like

Ensembl ID : ENSNBRG00000011328
Gene Symbol: LOC102791036
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).